Reply to cochrane neuraminidase inhibitors review team

Clinical Infectious Diseases

Volumn 53, Issue 12, 2011, Pages 1303-1304

  Hernán, Miguel A ^a,b   Lipsitch, Marc ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; OSELTAMIVIR;

HUMAN; LETTER; LOWER RESPIRATORY TRACT INFECTION; META ANALYSIS (TOPIC); OTITIS MEDIA; PRIORITY JOURNAL; SINUSITIS; TONSILLITIS;

EID: 81855211505     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir717     Document Type: Letter

References (7)

1. Del Mar C, Doshi P, Hama R, et al. Does oseltamivir really reduce complications of influenza? [letter to the editor] Clin Infect Dis 2011; 53:1302-30.
2. Hernán MA, Lipsitch M. Oseltamivir and risk of lower respiratory tract complications in patients with flu symptoms: a meta-analysis of eleven randomized clinical trials. Clin Infect Dis 2011; 53:277-9.
3. Jefferson T, Jones M, Doshi P, Del Mar C. Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis. BMJ 2009; 339: b5106.
4. Kaiser L, Wat C, Mills T, Mahoney P, Ward P, Hayden F. Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations. Arch Intern Med 2003; 163:1667-72. (Pubitemid 36898954)
5. Li L, Cai B, Wang M, Zhu Y. A double-blind, randomized, placebo-controlled multicenter study of oseltamivir phosphate for treatment of influenza infection in China. Chin Med J 2003; 116:44-8. (Pubitemid 36432720)
6. Lin J, Yue X, Cui D, et al. A multicenter randomized controlled trial of oseltamivir in the treatment of influenza in a high-risk Chinese population. Curr Med Res Opin 2006; 22: 75-82. (Pubitemid 43106910)
7. Deng W-W, Li Q-Y, Zhong N. "Oseltamivir in the treatment of suspected influenza patients" Study Group. A multicenter study of efficacy and safety of oseltamivir in the treatment of suspected influenza patients. Zhonghua Yi Xue Za Zhi 2004; 84:2132-6.